IDEAS home Printed from https://ideas.repec.org/a/spr/pharmo/v4y2020i2d10.1007_s41669-019-0172-x.html
   My bibliography  Save this article

Impact of a Clinical Pharmacist Intervention on Medicine Costs in Patients with Chronic Obstructive Pulmonary Disease in India

Author

Listed:
  • Suhaj Abdulsalim

    () (Qassim University
    MCOPS, Manipal Academy of Higher Education)

  • Mazhuvancherry Kesavan Unnikrishnan

    () (MCOPS, Manipal Academy of Higher Education
    National College of Pharmacy)

  • Mohan K. Manu

    () (Manipal Academy of Higher Education)

  • Saud Alsahali

    () (Qassim University)

  • Alian A. Alrasheedy

    () (Qassim University)

  • Antony P. Martin

    () (University of Liverpool Management School
    HCD Economics, The Innovation Centre)

  • Brian Godman

    () (University of Liverpool Management School
    University of Strathclyde
    Karolinska Institute, Karolinska University Hospital
    Universiti Sains Malaysia)

  • Abubakr A. Alfadl

    () (Qassim University)

Abstract

Background Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality, especially in low- and middle-income countries (LMICs) such as India. Medicine costs are a key issue in LMICs, with typically high patient co-payments. In addition, pharmacists are underutilised in LMICs, including India. However, pharmacist-led educational interventions may improve the care of patients with COPD, as well as reduce medicine costs. Consequently, the objective of this study was to assess the effectiveness of a pharmacist-led intervention in reducing medicine costs. Methodology We assessed the impact of a pharmacist intervention on direct medicine costs in COPD patients (medicine costs and pharmacist time) in a randomised controlled study involving an intervention and control group, conducted at a tertiary care teaching hospital in India. Results The 6-monthly cost of medicines at baseline increased with disease severity, from a maximum of US$29.46 for those with mild COPD to US$63.28 for those with very severe COPD. Substantial savings in medical costs were achieved with the pharmacist-led programme, to a maximum of US$20.49 over 6 months for very severe patients. This equates to a reduction of 30.6% in medicine costs (p

Suggested Citation

  • Suhaj Abdulsalim & Mazhuvancherry Kesavan Unnikrishnan & Mohan K. Manu & Saud Alsahali & Alian A. Alrasheedy & Antony P. Martin & Brian Godman & Abubakr A. Alfadl, 2020. "Impact of a Clinical Pharmacist Intervention on Medicine Costs in Patients with Chronic Obstructive Pulmonary Disease in India," PharmacoEconomics - Open, Springer, vol. 4(2), pages 331-342, June.
  • Handle: RePEc:spr:pharmo:v:4:y:2020:i:2:d:10.1007_s41669-019-0172-x
    DOI: 10.1007/s41669-019-0172-x
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1007/s41669-019-0172-x
    File Function: Abstract
    Download Restriction: no
    ---><---

    Citations

    Blog mentions

    As found by EconAcademics.org, the blog aggregator for Economics research:
    1. Chris Sampson’s journal round-up for 1st June 2020
      by Chris Sampson in The Academic Health Economists' Blog on 2020-06-01 11:00:00

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:pharmo:v:4:y:2020:i:2:d:10.1007_s41669-019-0172-x. See general information about how to correct material in RePEc.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Sonal Shukla) or (Springer Nature Abstracting and Indexing). General contact details of provider: http://www.springer.com .

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service hosted by the Research Division of the Federal Reserve Bank of St. Louis . RePEc uses bibliographic data supplied by the respective publishers.